
Novartis India Q2 Results FY27: Net Loss Rs 77.54 Cr, Revenue Rs 56.05 Cr Down 37.95%
Updated: 4 Nov 2026 • 9:22 pm
Posted by:

Quick Answer
Novartis India Q2 Results FY27 were declared on 3 November 2026. Revenue stood at Rs 56.05 Cr, down 37.95% YoY from Rs 90.33 Cr, while net profit moved to a net loss of Rs 77.54 Cr from a profit of Rs 24.22 Cr a year earlier, a 420.15% YoY decline. These quarterly results show the YoY growth direction for both lines, with net profit margin at -138.3% against 26.8% in the comparison quarter.
Novartis India Ltd (NOVARTIND) Q2 Results FY27 announced on 3 November 2026, covering the company's financial performance for the July to September quarter. The results date brought revenue of Rs 56.05 Cr and a net loss of Rs 77.54 Cr into view, and Novartis India Q2 Results FY27 show revenue down 37.95% and net profit down 420.15% against a year earlier.
This results analysis of Novartis India Q2 Results covers the financial highlights, business drivers, outlook and risks behind the numbers. It begins with the Financial Highlights table, which sets this quarter against the same quarter last year.
Click Here – Get Free Investment Predictions
Novartis India Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 56.05 Cr | Rs 90.33 Cr | -37.95% YoY |
| Net Profit (PAT) | Rs -77.54 Cr | Rs 24.22 Cr | -420.15% YoY |
Source: company filing for Novartis India Q2 Results FY27, 3 November 2026. Figures in Rs Crore.
Key Takeaways from Novartis India Q2 Results: What Stands Out
- Revenue of Rs 56.05 Cr was 37.95% lower YoY than the Rs 90.33 Cr reported in the same quarter of last year.
- A net loss of Rs 77.54 Cr compares with net profit of Rs 24.22 Cr a year earlier, a 420.15% YoY decline for Novartis India Q2 Results FY27.
- Net profit margin of -138.3% compares with 26.8% in the comparison quarter, as supplied for the latest quarter.
- Return on capital employed of 16.34% and a debt-to-assets ratio of 0.00 are the FY26 measures reported alongside this quarter.
- Net profit volatility over the last five quarters is the main risk headline, which leads into the performance analysis.
Novartis India Q2 Results FY27: Performance Analysis
This results analysis of Novartis India Q2 Results FY27 starts with the two headline lines. Revenue was Rs 56.05 Cr in the July to September 2026 quarter, down 37.95% YoY, while net profit moved to a net loss of Rs 77.54 Cr, a 420.15% YoY decline from the Rs 24.22 Cr profit of the year before.
The same quarter last year showed revenue of Rs 90.33 Cr and net profit of Rs 24.22 Cr. Revenue therefore fell by a little more than a third while net profit moved from a profit to a loss, and that shows up as a net profit margin of -138.3% against 26.8%. Novartis India Q2 Results make the margin the figure that differs most between the two periods.
Novartis India Q2 Results FY27 should be read as quarterly results measured YoY against the same quarter of last year, with YoY growth negative for both lines. The supplied figures confirm what changed but do not establish the specific cause of the movement, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Return on Capital Employed – The results analysis points first to return on capital employed, which was 16.34% in FY26. For Novartis India Q2 Results FY27, this is a full-year measure and sits beside quarterly revenue of Rs 56.05 Cr and a net loss of Rs 77.54 Cr.
Debt Position – The company is almost debt free, with a debt-to-assets ratio of 0.00 in FY26. It is reported alongside the quarterly results and is not tied to any single quarter's revenue or profit movement.
FY27 Outlook After Novartis India Q2 Results
The FY27 picture will be shaped by the quarters still to be declared and by disclosed sector conditions, and this results analysis does not stretch the Q2 numbers into a forecast. The net loss of Rs 77.54 Cr and revenue of Rs 56.05 Cr are the reference points that later quarters will be read against.
Investors who want to follow what comes next can track later filings from Novartis India on the Univest Screener and the Univest app. Novartis India Q2 Results FY27 give the base for that tracking, and the risks below show where the reported numbers call for attention.
Key Risks to Watch After Novartis India Q2 Results FY27
Revenue Decline
Revenue declined 37.9% year on year to Rs 56.05 Cr in the latest quarter. After Novartis India Q2 Results FY27, this movement is the first risk to watch when the next quarterly filing is declared.
Net Loss and Margin
The company reported a net loss of Rs 77.54 Cr in the latest quarter, and net profit margin narrowed to -138.3% from 26.8% in the comparison quarter. The next YoY growth reading will show where net profit and margin stand.
Net Profit Volatility
Quarterly net profit has been volatile, ranging from Rs -77.54 Cr to Rs 32.21 Cr over the last 5 quarters. That range is a balance sheet and earnings point that investors can track in later filings alongside revenue.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Novartis India Q2 Results FY27 show revenue of Rs 56.05 Cr and a net loss of Rs 77.54 Cr for the July to September 2026 quarter. Taken together, these quarterly results show a 37.95% YoY revenue decline and a 420.15% YoY net profit decline on a reported basis. Anyone reading Novartis India Q2 Results FY27 should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Novartis India Q2 Results FY27
What are Novartis India Q2 Results FY27?
Ans. Novartis India Q2 Results FY27 are the quarterly results for July to September 2026. Alongside this, revenue was Rs 56.05 Cr and the company reported a net loss of Rs 77.54 Cr, as the Financial Highlights table shows.
What is the results date for Novartis India Q2 Results FY27?
Ans. The results date for Novartis India Q2 Results FY27 is 3 November 2026, when the numbers for July to September 2026 were declared. This is why the opening paragraphs of the article state that date first.
What revenue was reported in Novartis India Q2 Results FY27?
Ans. Novartis India reported revenue of Rs 56.05 Cr in Q2 FY27, compared with Rs 90.33 Cr in the same quarter last year, as the Performance Analysis section sets out in detail.
What net profit was reported in Novartis India Q2 Results FY27?
Ans. Novartis India reported a net loss of Rs 77.54 Cr in Q2 FY27, compared with net profit of Rs 24.22 Cr a year earlier, which the Financial Highlights and Performance Analysis sections cover in detail.
How much YoY growth did revenue show in Novartis India Q2 Results FY27?
Ans. Revenue in Novartis India Q2 Results FY27 fell 37.95% YoY, from Rs 90.33 Cr to Rs 56.05 Cr. Alongside this, net profit fell 420.15% YoY, as the Key Takeaways section shows.
Did net profit rise or fall in Novartis India Q2 Results?
Ans. Net profit fell in Novartis India Q2 Results, moving to a net loss of Rs 77.54 Cr from Rs 24.22 Cr, a 420.15% YoY decline. This sits beside a 37.95% revenue decline, as the Performance Analysis section explains.
What was the net profit margin in Novartis India Q2 Results FY27?
Ans. Net profit margin was -138.3% in Novartis India Q2 Results FY27, compared with 26.8% in the comparison quarter. This narrowing is covered in the Key Risks section, which lists the margin alongside revenue and net profit.
What did Novartis India report a year earlier in Novartis India Q2 Results?
Ans. In the same quarter last year, Novartis India Q2 Results show revenue of Rs 90.33 Cr and net profit of Rs 24.22 Cr. These prior-year figures are the YoY base used in the Financial Highlights table.
What business factors shaped Novartis India Q2 Results FY27?
Ans. Novartis India Q2 Results FY27 list a FY26 return on capital employed of 16.34% and a FY26 debt-to-assets ratio of 0.00 as disclosed factors. The Key Business Factors section describes each one in turn.
What are the key risks after Novartis India Q2 Results FY27?
Ans. The risks after Novartis India Q2 Results FY27 are the 37.9% YoY revenue decline, the net loss of Rs 77.54 Cr with a narrower margin, and net profit volatility, while the Key Risks section explains each.
What is the outlook after Novartis India Q2 Results?
Ans. The outlook after Novartis India Q2 Results rests on the quarters still to be declared in FY27 and on disclosed sector conditions. This means the FY27 Outlook section stays with reported figures and adds no forecast.
Where can I find the complete Novartis India Q2 Results FY27 data?
Ans. The complete Novartis India Q2 Results FY27 data is in the Financial Highlights table of this article, which sets the quarter against last year. Alongside this, the Univest Screener lets readers follow later filings from the company.
Recent Articles

Mazda Q2 Results FY27: Net Profit Jumps 113.32% to Rs 16.17 Cr, Revenue Rs 83.17 Cr
4 November 2026

Jayant Agro-Organics Q2 Results FY27: Net Profit Jumps 134.74% to Rs 21.62 Cr, Revenue Rs 787.35 Cr
4 November 2026

Redington Q2 Results FY27: Revenue Jumps 47.71% to Rs 42,946.91 Cr, PAT Rs 422.51 Cr
4 November 2026

Saurashtra Cement Q2 Results FY27: Net Loss Narrows 21.94% to Rs 8.61 Cr, Revenue Rs 376.73 Cr, PAT Rs -8.61 Cr
4 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Mazda Q2 Results FY27: Net Profit Jumps 113.32% to Rs 16.17 Cr, Revenue Rs 83.17 Cr
Jayant Agro-Organics Q2 Results FY27: Net Profit Jumps 134.74% to Rs 21.62 Cr, Revenue Rs 787.35 Cr
Redington Q2 Results FY27: Revenue Jumps 47.71% to Rs 42,946.91 Cr, PAT Rs 422.51 Cr
Saurashtra Cement Q2 Results FY27: Net Loss Narrows 21.94% to Rs 8.61 Cr, Revenue Rs 376.73 Cr, PAT Rs -8.61 Cr
Platinum Industries Q2 Results FY27: Profit Falls 30.78%, Revenue Rs 121.27 Cr, PAT Rs 7.60 Cr
Popular this week
The Investment Trust of India Q2 Results FY27: Profit Falls 76.11%, Revenue Rs 52.61 Cr, PAT Rs 1.34 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





